Overview of Clinical Trial Participation
February 1st, 2024 | 3:00 PM Eastern
Presented by: Jonathan Hogan, MD
Senior Medical Director, Cabaletta Bio
During this webinar, we will provide an overview of clinical trial participation and review Cabaletta’s CD19-Chimeric Antigen Receptor (CAR) T study for people with generalized myasthenia gravis and Cabaletta’s MuSK-CAART study for people with MuSK-positive myasthenia gravis.